Table 1. Clinical features of 45 patients undergoing diagnostic biopsy – cohort two.
| Variable | |
|---|---|
|
| |
| Age (mean ± S.E.) | 67.07 ± 1.7 |
|
| |
| Sex (male/female) | 39/6 |
|
| |
| BMI (mean ± S.E.) | 28.8 ± 1.2 |
|
| |
| Type 2 Diabetes Y/N | 24/21 |
|
| |
| Cirrhosis Y/N | 25/20 |
|
| |
| Etiology | |
| None | 18 |
| ALD | 9 |
| NAFLD | 7 |
| HCV | 3 |
| AIH | 2 |
| Haemochromatosis | 3 |
| Cryptogenic | 3 |
|
| |
| Edmondson Grade 1/2/3 | 13/23/9 |
|
| |
| Size (cm) (mean ± S.E.) | 6.3 ± 0.70 |
|
| |
| Number (mean ± S.E.) | 2.47 ± 0.47 |
|
| |
| PVT Y:N | 6/32 |
|
| |
| Extra-hepatic disease Y:N | 6/39 |
|
| |
| INR (mean ± S.E.) | 1.02 ± 0.02 |
|
| |
| Albumin (g/l) (mean ± S.E.) | 37.7 ± 0.89 |
|
| |
| Bilirubin (μmol/l) | 25.7 ± 10.50 |
|
| |
| Ascites Y:N | 5/40 |
|
| |
| Encephalopathy Y:N | 0/44 |
|
| |
| Childs-Pugh A/B/C | 39/5/1 |
|
| |
| BCLC A/B/C/D | 14/9/20/2 |
|
| |
| Median survival (months) | 24.60 |
Continuous data are presented as mean ± standard error. ALD – alcoholic liver disease; NAFLD – nonalcoholic fatty liver disease; HCV – hepatitis C virus; HBV – hepatitis B virus; AIH – autoimmune hepatitis; BMI – Body Mass Index; PVT – portal vein thrombosis; INR – international normalised ratio; BCLC – Barcelona Clinic for Liver Cancer